Ketamine hydrochloride

Product NDC
70121-2629
Requested package NDC
70121-2629-3
11-digit product format
701212629
Labeler code
70121
Product ID
70121-2629_55b66c25-8d9f-4f7b-abff-80b903aa29ae
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ketamine hydrochloride
Dosage form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Amneal Pharmaceuticals LLC
Application
ANDA220380
Marketing category
ANDA
Marketing start
2026-11-16
Substance
KETAMINE HYDROCHLORIDE
Active strength
50 mg/mL
Pharmacologic classes
General Anesthesia [PE], General Anesthetic [EPC]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220380-001KETAMINE HYDROCHLORIDEKETAMINE HYDROCHLORIDEEQ 50MG BASE/5ML (EQ 10MG BASE/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSAP2026-11-04
A220380-002KETAMINE HYDROCHLORIDEKETAMINE HYDROCHLORIDEEQ 50MG BASE/ML (EQ 50MG BASE/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRS2026-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A220380-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220380-001KETAMINE HYDROCHLORIDEEQ 50MG BASE/5ML (EQ 10MG BASE/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSAP2026-11-04d4dbc9d85df4…
2026-11-14 07:37:172026-10A220380-002KETAMINE HYDROCHLORIDEEQ 50MG BASE/ML (EQ 50MG BASE/ML)SOLUTION / INTRAMUSCULAR, INTRAVENOUSRS2026-11-04d4dbc9d85df4…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220380-001AP1d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Ketamine hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
KETAMINE HYDROCHLORIDE50 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O18YUO0I83Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
64a483f2-eb08-4993-84ce-9d8ddc757f2cAvailable on FDA.report

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70121-2629-37012126290310 SYRINGE, GLASS in 1 CARTON (70121-2629-3) / 1 mL in 1 SYRINGE, GLASS2026-11-16NoNoCurrent